During the past decade, Central PA Asth & Allergy Care; Research Division conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central PA Asth & Allergy Care; Research Division" are "Asthma" (2 trials). Many other conditions were trialed in "Central PA Asth & Allergy Care; Research Division" in a lesser frequency.

Most popular intervention types in "Central PA Asth & Allergy Care; Research Division" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (1 trials), "Omalizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central PA Asth & Allergy Care; Research Division" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central PA Asth & Allergy Care; Research Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central PA Asth & Allergy Care; Research Division, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central PA Asth & Allergy Care; Research Division, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".